Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer

@article{Su2016DiallylDS,
  title={Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer},
  author={B. Su and J. Su and Y. Zeng and F. Liu and Hong Xia and Yan-hua Ma and Z. Zhou and S. Zhang and Bang-Min Yang and Y. Wu and X. Zeng and X. Ai and H. Ling and H. Jiang and Q. Su},
  journal={Oncotarget},
  year={2016},
  volume={7},
  pages={10498 - 10512}
}
  • B. Su, J. Su, +12 authors Q. Su
  • Published 2016
  • Medicine
  • Oncotarget
  • Diallyl disulfide (DADS) has been shown to have multi-targeted antitumor activities. We have previously discovered that it has a repressive effect on LIM kinase-1 (LIMK1) expression in gastric cancer MGC803 cells. This suggests that DADS may inhibit epithelial-mesenchymal transition (EMT) by downregulating LIMK1, resulting in the inhibition of invasion and growth in gastric cancer. In this study, we reveal that LIMK1 expression is correlated with tumor differentiation, invasion depth, clinical… CONTINUE READING
    MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells
    6

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 46 REFERENCES
    Erk is involved in the differentiation induced by diallyl disulfide in the human gastric cancer cell line MGC803
    36